<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7102521/results/search/disease/results.xml">
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="Central and other publicly funded repositories, such as the WHO" exact="COVID" post="database with rights for unrestricted research re-use and analyses"/>
  <result pre="identify Chinese medical herbs that are commonly used in treating" exact="viral" post="respiratory infections and also contain compounds that might directly"/>
  <result pre="Chinese medical herbs that are commonly used in treating viral" exact="respiratory" post="infections and also contain compounds that might directly inhibit"/>
  <result pre="medical herbs that are commonly used in treating viral respiratory" exact="infections" post="and also contain compounds that might directly inhibit 2019"/>
  <result pre="natural compounds that had been biologically confirmed as against sever" exact="acute" post="respiratory syndrome coronavirus or Middle East respiratory syndrome coronavirus."/>
  <result pre="compounds that had been biologically confirmed as against sever acute" exact="respiratory" post="syndrome coronavirus or Middle East respiratory syndrome coronavirus. Resulting"/>
  <result pre="that had been biologically confirmed as against sever acute respiratory" exact="syndrome" post="coronavirus or Middle East respiratory syndrome coronavirus. Resulting compounds"/>
  <result pre="as against sever acute respiratory syndrome coronavirus or Middle East" exact="respiratory" post="syndrome coronavirus. Resulting compounds were cross-checked for listing in"/>
  <result pre="against sever acute respiratory syndrome coronavirus or Middle East respiratory" exact="syndrome" post="coronavirus. Resulting compounds were cross-checked for listing in the"/>
  <result pre="Of these 125 herbs, 26 are classically catalogued as treating" exact="viral" post="respiratory infections. Network pharmacology analysis predicted that the general"/>
  <result pre="these 125 herbs, 26 are classically catalogued as treating viral" exact="respiratory" post="infections. Network pharmacology analysis predicted that the general in"/>
  <result pre="roles of these 26 herbal plants were related to regulating" exact="viral infection," post="immune/inflammation reactions and hypoxia response. Conclusion Chinese herbal treatments"/>
  <result pre="plants were related to regulating viral infection, immune/inflammation reactions and" exact="hypoxia" post="response. Conclusion Chinese herbal treatments classically used for treating"/>
  <result pre="hypoxia response. Conclusion Chinese herbal treatments classically used for treating" exact="viral" post="respiratory infection might contain direct anti-2019-nCoV compounds. Keywords 2019-nCoV"/>
  <result pre="response. Conclusion Chinese herbal treatments classically used for treating viral" exact="respiratory" post="infection might contain direct anti-2019-nCoV compounds. Keywords 2019-nCoV Wuhan"/>
  <result pre="Conclusion Chinese herbal treatments classically used for treating viral respiratory" exact="infection" post="might contain direct anti-2019-nCoV compounds. Keywords 2019-nCoV Wuhan coronavirus"/>
  <result pre="direct anti-2019-nCoV compounds. Keywords 2019-nCoV Wuhan coronavirus Drugs Chinese herbal" exact="Pneumonia" post="Natural compounds Molecular docking Network pharmacology 1 Introduction Toward"/>
  <result pre="in China and spread to other countries in a very" exact="short" post="time. On January 30, 2020, the Director-General of the"/>
  <result pre="agents are the most effective methods to prevent and treat" exact="viral infection," post="there are not yet effective treatments that target the"/>
  <result pre="this end. The effectiveness of herbal treatment to control contagious" exact="disease" post="was demonstrated during the 2003 severe acute respiratory syndrome"/>
  <result pre="to control contagious disease was demonstrated during the 2003 severe" exact="acute" post="respiratory syndrome (SARS) outbreak [3]. As such, the Chinese"/>
  <result pre="control contagious disease was demonstrated during the 2003 severe acute" exact="respiratory" post="syndrome (SARS) outbreak [3]. As such, the Chinese government"/>
  <result pre="contagious disease was demonstrated during the 2003 severe acute respiratory" exact="syndrome" post="(SARS) outbreak [3]. As such, the Chinese government is"/>
  <result pre="encouraging the use of herbal plants in fighting this new" exact="viral pneumonia." post="However, the application of herbal treatment is mainly guided"/>
  <result pre="predetermine whether the herbs in question can directly target the" exact="viral" post="cause, in other words, herbal usage is generally not"/>
  <result pre="in other words, herbal usage is generally not guided by" exact="viral" post="pathology. We think more detailed knowledge about the direct"/>
  <result pre="than one dozen proteins, some of which are essential to" exact="viral" post="entry and replication. Among these proteins, the most well-studied"/>
  <result pre="(3CLpro) and spike protein. Coronavirus PLpro not only processes the" exact="viral" post="polypeptide onto functional proteins but is also a deubiquitinating"/>
  <result pre="[13], [14]. SARS-3CLpro is a cysteine protease indispensable to the" exact="viral" post="life cycle [15]. Coronavirus spike protein uses angiotensin-converting enzyme"/>
  <result pre="directly inhibit these important proteins in SARS or Middle East" exact="respiratory" post="syndrome (MERS) coronavirus [17], [18], [19], [20], [21], [22],"/>
  <result pre="inhibit these important proteins in SARS or Middle East respiratory" exact="syndrome" post="(MERS) coronavirus [17], [18], [19], [20], [21], [22], [23]."/>
  <result pre="herbal plants among the traditional Chinese herbs used to treat" exact="viral pneumonia." post="It is a challenge to screen out the herbs"/>
  <result pre="used for patients infected with this pathogen, especially in very" exact="short" post="time. Here, we propose two principles to guide such"/>
  <result pre="effective anti-coronavirus (2019-nCoV) compounds and are classified as treating virus-caused" exact="respiratory" post="infection. 2 Materials and methods 2.1 Literature search and"/>
  <result pre="the corresponding proteins from SARS-CoV. The models built were of" exact="Protein" post="Data Bank (PDB) format. (2) To retrieve the required"/>
  <result pre="2.4 Plant selection Herbs were selected through three steps. (1)" exact="Primary" post="selection: molecules chosen from the above steps were used"/>
  <result pre="more antiviral compounds were selected for the next step. (2)" exact="Classic" post="usage catalogue cross-reference: only herbs traditionally used to treat"/>
  <result pre="Classic usage catalogue cross-reference: only herbs traditionally used to treat" exact="viral" post="respiratory infection were retained for further study. (3) Predication"/>
  <result pre="usage catalogue cross-reference: only herbs traditionally used to treat viral" exact="respiratory" post="infection were retained for further study. (3) Predication of"/>
  <result pre="catalogue cross-reference: only herbs traditionally used to treat viral respiratory" exact="infection" post="were retained for further study. (3) Predication of general"/>
  <result pre="their reported targets. If the molecules were reported to inhibit" exact="viral" post="entry, they were docked with spike proteins (Table 1"/>
  <result pre="to form a dimmer [30]. M6 was reported to inhibit" exact="viral" post="entry, accordingly it bound the fusion cone of spike"/>
  <result pre="cone of spike protein; this cone structure is important for" exact="viral" post="membrane fusion [31] (Fig. 2 and online supplementary Fig."/>
  <result pre="Methods. The protein structure files are listed in Table 1." exact="Protein" post="domains are shown in different colors, while natural compounds"/>
  <result pre="finally choosing 11 types that are traditionally used to treat" exact="viral" post="respiratory infections. There are 26 herbal plants within the"/>
  <result pre="choosing 11 types that are traditionally used to treat viral" exact="respiratory" post="infections. There are 26 herbal plants within the 11"/>
  <result pre="the 11 types. The timeframe during the course of a" exact="viral infection" post="that each of these 26 herbal plants (Table 2"/>
  <result pre="11 types. The timeframe during the course of a viral" exact="infection" post="that each of these 26 herbal plants (Table 2"/>
  <result pre="and the possible time for usage. No. Herbal name Number*" exact="Classic" post="catalogue Time to use Latin Chinese Latin/English Chinese 1"/>
  <result pre="30 KEGG-enriched pathways (mean = 11) were related to regulating" exact="viral infection," post="immune/inflammatory reactions and hypoxia response, indicating that they are"/>
  <result pre="11) were related to regulating viral infection, immune/inflammatory reactions and" exact="hypoxia" post="response, indicating that they are potentially effective treatments for"/>
  <result pre="hypoxia response, indicating that they are potentially effective treatments for" exact="viral" post="respiratory infection (Fig. 3 and online supplementary Fig. S2)."/>
  <result pre="response, indicating that they are potentially effective treatments for viral" exact="respiratory" post="infection (Fig. 3 and online supplementary Fig. S2). Note"/>
  <result pre="indicating that they are potentially effective treatments for viral respiratory" exact="infection" post="(Fig. 3 and online supplementary Fig. S2). Note that"/>
  <result pre="selected here had been reported to be effective for SARS-CoV" exact="infection" post="in 2003 (online supplementary Table S2). Fig. 3 Kyoto"/>
  <result pre="blue, red and green bars represent the pathways related to" exact="viral infection," post="immune/inflammation response, and hypoxia response, respectively. EGFR: epidermal growth"/>
  <result pre="represent the pathways related to viral infection, immune/inflammation response, and" exact="hypoxia" post="response, respectively. EGFR: epidermal growth factor receptor; AGE: advanced"/>
  <result pre="providing instant help in the prevention and treatment of the" exact="pneumonia" post="that it can cause. While mainly in China at"/>
  <result pre="it can cause. While mainly in China at this point," exact="viral" post="spread is ongoing and has affect persons worldwide. Two"/>
  <result pre="we verified that they have been routinely used to treat" exact="viral pneumonia." post="To meet this principle, we conducted another three-step screening"/>
  <result pre="2 of these potentially useful compounds were selected, and a" exact="total" post="of 125 herbal plants were identified. The second step"/>
  <result pre="26 herbs were found to be routinely used in treating" exact="viral" post="respiratory infection. Finally, network pharmacological analysis was performed to"/>
  <result pre="herbs were found to be routinely used in treating viral" exact="respiratory" post="infection. Finally, network pharmacological analysis was performed to predict"/>
  <result pre="enriched in KEGG are related to antiviral, immune/inflammatory responses and" exact="hypoxia" post="response indicating that these herbs are suitable for anti-viral"/>
  <result pre="plants selected here had been reported effective in against SARS-CoV" exact="infection" post="in 2003 (online supplementary Table S2). We thought that"/>
  <result pre="6KeselA.J.Synthesis of novel test compounds for antiviral chemotherapy of severe" exact="acute" post="respiratory syndrome (SARS)Curr Med Chem121820052095216216101496 7WuC.Y.JanJ.T.MaS.H.KuoC.J.JuanH.F.ChengY.S.Small molecules targeting severe"/>
  <result pre="of novel test compounds for antiviral chemotherapy of severe acute" exact="respiratory" post="syndrome (SARS)Curr Med Chem121820052095216216101496 7WuC.Y.JanJ.T.MaS.H.KuoC.J.JuanH.F.ChengY.S.Small molecules targeting severe acute"/>
  <result pre="novel test compounds for antiviral chemotherapy of severe acute respiratory" exact="syndrome" post="(SARS)Curr Med Chem121820052095216216101496 7WuC.Y.JanJ.T.MaS.H.KuoC.J.JuanH.F.ChengY.S.Small molecules targeting severe acute respiratory"/>
  <result pre="acute respiratory syndrome (SARS)Curr Med Chem121820052095216216101496 7WuC.Y.JanJ.T.MaS.H.KuoC.J.JuanH.F.ChengY.S.Small molecules targeting severe" exact="acute" post="respiratory syndrome human coronavirusProc Natl Acad Sci U S"/>
  <result pre="respiratory syndrome (SARS)Curr Med Chem121820052095216216101496 7WuC.Y.JanJ.T.MaS.H.KuoC.J.JuanH.F.ChengY.S.Small molecules targeting severe acute" exact="respiratory" post="syndrome human coronavirusProc Natl Acad Sci U S A101272004100121001715226499"/>
  <result pre="syndrome (SARS)Curr Med Chem121820052095216216101496 7WuC.Y.JanJ.T.MaS.H.KuoC.J.JuanH.F.ChengY.S.Small molecules targeting severe acute respiratory" exact="syndrome" post="human coronavirusProc Natl Acad Sci U S A101272004100121001715226499 8LiuB.ZhouJ.SARS-CoV"/>
  <result pre="innate and adaptive immunityNature4587237200943043719325622 14IsaacsonM.K.PloeghH.L.Ubiquitination, ubiquitin-like modifiers, and deubiquitination in" exact="viral" post="infectionCell Host Microbe56200955957019527883 15MukherjeeP.ShahF.DesaiP.AveryM.Inhibitors of SARS-3CLpro: virtual screening, biological"/>
  <result pre="plant terpenoids and lignoids possess potent antiviral activities against severe" exact="acute" post="respiratory syndrome coronavirusJ Med Chem501720074087409517663539 18RyuY.B.ParkS.J.KimY.M.LeeJ.Y.SeoW.D.ChangJ.S.SARS-CoV 3CLpro inhibitory effects"/>
  <result pre="terpenoids and lignoids possess potent antiviral activities against severe acute" exact="respiratory" post="syndrome coronavirusJ Med Chem501720074087409517663539 18RyuY.B.ParkS.J.KimY.M.LeeJ.Y.SeoW.D.ChangJ.S.SARS-CoV 3CLpro inhibitory effects of"/>
  <result pre="and lignoids possess potent antiviral activities against severe acute respiratory" exact="syndrome" post="coronavirusJ Med Chem501720074087409517663539 18RyuY.B.ParkS.J.KimY.M.LeeJ.Y.SeoW.D.ChangJ.S.SARS-CoV 3CLpro inhibitory effects of quinone-methide"/>
  <result pre="and identification of potent broad-spectrum inhibitors of coronavirusesJ Virol93122019e00023e11930918074 24ZhouP.YangX.L.WangX.G.HuB.ZhangL.ZhangW.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
  <result pre="a pseudovirus expressing MERS-CoV spike proteinInt J Antimicrob Agents525201873073229772395 29RatiaK.SaikatenduK.S.SantarsieroB.D.BarrettoN.BakerS.C.StevensR.C.Severe" exact="acute" post="respiratory syndrome coronavirus papain-like protease: structure of a viral"/>
  <result pre="pseudovirus expressing MERS-CoV spike proteinInt J Antimicrob Agents525201873073229772395 29RatiaK.SaikatenduK.S.SantarsieroB.D.BarrettoN.BakerS.C.StevensR.C.Severe acute" exact="respiratory" post="syndrome coronavirus papain-like protease: structure of a viral deubiquitinating"/>
  <result pre="expressing MERS-CoV spike proteinInt J Antimicrob Agents525201873073229772395 29RatiaK.SaikatenduK.S.SantarsieroB.D.BarrettoN.BakerS.C.StevensR.C.Severe acute respiratory" exact="syndrome" post="coronavirus papain-like protease: structure of a viral deubiquitinating enzymeProc"/>
  <result pre="29RatiaK.SaikatenduK.S.SantarsieroB.D.BarrettoN.BakerS.C.StevensR.C.Severe acute respiratory syndrome coronavirus papain-like protease: structure of a" exact="viral" post="deubiquitinating enzymeProc Natl Acad Sci U S A1031520065717572216581910 30AnandK.ZiebuhrJ.WadhwaniP.MestersJ.R.HilgenfeldR.Coronavirus"/>
  <result pre="basis for design of anti-SARS drugsScience300562620031763176712746549 31XuY.LouZ.LiuY.PangH.TienP.GaoG.F.Crystal structure of severe" exact="acute" post="respiratory syndrome coronavirus spike protein fusion coreJ Biol Chem279472004494144941915345712"/>
  <result pre="for design of anti-SARS drugsScience300562620031763176712746549 31XuY.LouZ.LiuY.PangH.TienP.GaoG.F.Crystal structure of severe acute" exact="respiratory" post="syndrome coronavirus spike protein fusion coreJ Biol Chem279472004494144941915345712 32ZhangW.HuaiY.MiaoZ.QianA.WangY.Systems"/>
  <result pre="design of anti-SARS drugsScience300562620031763176712746549 31XuY.LouZ.LiuY.PangH.TienP.GaoG.F.Crystal structure of severe acute respiratory" exact="syndrome" post="coronavirus spike protein fusion coreJ Biol Chem279472004494144941915345712 32ZhangW.HuaiY.MiaoZ.QianA.WangY.Systems pharmacology"/>
 </snippets>
</snippetsTree>
